Concerns over the immunogenicity of poly(ethylene glycol) (PEG) are growing, and the implications for tissue engineering are unknown. Here the authors evaluate the impact of anti-PEG antibodies and PEG immunogenicity on the efficacy of a PEG hydrogel-based tissue engineering therapy.
All Keywords
【저자키워드】 antibodies, biomedical engineering, Biomaterials - proteins,
【저자키워드】 antibodies, biomedical engineering, Biomaterials - proteins,